Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Grossman

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Association between hyperglycemia and survival in patients with newly diagnosed glioblastomaRachel L Derr, Xiaobu Ye, Melissa U Islas, et al.
Cancer|December 13, 2006
Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxisDavid E Gerber, Jodi B Segal, Amandeep Salhotra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United StatesStuart A Grossman, Xiaobu Ye, Steven Piantadosi, et al.
Journal of Neuro-Oncology|June 24, 2015
A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factorsMichael B Streiff, Xiaobu Ye, Thomas S Kickler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07Tracy Batchelor, Kathryn Carson, Alison O'Neill, et al.
Journal of Biomedical Materials Research. Part A|September 3, 2011
A novel polymer gel for the delivery of local therapies to intracranial tumors: In vivo safety evaluationDavid E Gerber, Gary L Gallia, Betty M Tyler, et al.
Neurology|June 15, 2014
High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphomaMatthias Holdhoff, Prakash Ambady, Ahmed Abdelaziz, et al.
Advances in Radiation Oncology|August 5, 2022
Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation TherapySusannah G Ellsworth, Anirudh Yalamanchali, Tim Lautenschlaeger, et al.
Neuro-Oncology|February 11, 2012
Phase I study of terameprocol in patients with recurrent high-grade gliomaStuart A Grossman, Xiaobu Ye, David Peereboom, et al.
Investigational New Drugs|November 3, 2006
Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiformeTom Mikkelsen, Richard Lush, Stuart A Grossman, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Association between hyperglycemia and survival in patients with newly diagnosed glioblastomaRachel L Derr, Xiaobu Ye, Melissa U Islas, et al.
Cancer|December 13, 2006
Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxisDavid E Gerber, Jodi B Segal, Amandeep Salhotra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United StatesStuart A Grossman, Xiaobu Ye, Steven Piantadosi, et al.
Journal of Neuro-Oncology|June 24, 2015
A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factorsMichael B Streiff, Xiaobu Ye, Thomas S Kickler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07Tracy Batchelor, Kathryn Carson, Alison O'Neill, et al.
Journal of Biomedical Materials Research. Part A|September 3, 2011
A novel polymer gel for the delivery of local therapies to intracranial tumors: In vivo safety evaluationDavid E Gerber, Gary L Gallia, Betty M Tyler, et al.
Neurology|June 15, 2014
High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphomaMatthias Holdhoff, Prakash Ambady, Ahmed Abdelaziz, et al.
Advances in Radiation Oncology|August 5, 2022
Lymphocyte Depletion Rate as a Biomarker of Radiation Dose to Circulating Lymphocytes During Fractionated Partial-Body Radiation TherapySusannah G Ellsworth, Anirudh Yalamanchali, Tim Lautenschlaeger, et al.
Neuro-Oncology|February 11, 2012
Phase I study of terameprocol in patients with recurrent high-grade gliomaStuart A Grossman, Xiaobu Ye, David Peereboom, et al.
Investigational New Drugs|November 3, 2006
Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiformeTom Mikkelsen, Richard Lush, Stuart A Grossman, et al.
Pageof 18